Zobrazeno 1 - 10
of 58
pro vyhledávání: '"M Villaronga"'
Autor:
L. Marti-Sanchez, J. D. Ortigoza-Escobar, A. Darling, M. Villaronga, H. Baide, M. Molero-Luis, M. Batllori, M. I. Vanegas, J. Muchart, L. Aquino, R. Artuch, A. Macaya, M. A. Kurian, Pérez Dueñas
Publikováno v:
Orphanet Journal of Rare Diseases, Vol 13, Iss 1, Pp 1-8 (2018)
Abstract Background The SLC39A14, SLC30A10 and SLC39A8 are considered to be key genes involved in manganese (Mn) homeostasis in humans. Mn levels in plasma and urine are useful tools for early recognition of these disorders. We aimed to explore furth
Externí odkaz:
https://doaj.org/article/23d5f411c5bc4037ad9c1d9130d81edf
Publikováno v:
Section 4: Clinical pharmacy services.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::bc8e327db1f7f1fb8bb0f8736ac63ba8
https://doi.org/10.1136/ejhpharm-2023-eahp.219
https://doi.org/10.1136/ejhpharm-2023-eahp.219
Publikováno v:
Section 4: Clinical pharmacy services.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5dddd757d1b306c6170fbc38bb63e800
https://doi.org/10.1136/ejhpharm-2023-eahp.208
https://doi.org/10.1136/ejhpharm-2023-eahp.208
Autor:
A Font, E Wilhelmi, M Villaronga, D Gavrus, J Vendrell, LE Veloz, JD Yunga, A Casaldàliga, CJ Moreno, R Farré
Publikováno v:
Late breaking abstracts.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::952bbb8c4bae5c849c9465c7d7997d7d
https://doi.org/10.1136/ejhpharm-2023-eahp.368
https://doi.org/10.1136/ejhpharm-2023-eahp.368
Autor:
E Wilhelmi, S Ferro, A Font, A Casaldáliga, CJ Moreno, Á Pieras, M Villaronga, R Farré, R Berrueco
Publikováno v:
Section 5: Patient safety and quality assurance.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::db8f9abe3b65ec479110a70572078cc0
https://doi.org/10.1136/ejhpharm-2023-eahp.291
https://doi.org/10.1136/ejhpharm-2023-eahp.291
Autor:
M Sánchez Celma, M Villaronga Flaqué, D Gavrus Ion, F Bossacoma Busquets, R Farré Riba, JM Català Foguet, JA Cuartero Lozano
Publikováno v:
Section 3: Production and Compounding.
Background and importance In a paediatric hospital, we often face the lack of commercially available medicines suitable or even licensed for use in paediatrics. Furthermore, authorised paediatric medicines, especially in younger children and neonates
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::eda1bfce82761f5e2ad8a3bf1e477f0e
https://doi.org/10.1136/ejhpharm-2020-eahpconf.95
https://doi.org/10.1136/ejhpharm-2020-eahpconf.95
Autor:
R Farré Riba, JM Català Foguet, D Gavrus Ion, M Sánchez Celma, F Bossacoma Busquets, M Villaronga Flaqué
Publikováno v:
Section 3: Production and Compounding.
Background and importance Paediatric pharmacy often faces a lack of commercially available medicines suitable or even licensed for use in children. Children cannot be regarded as small adults or as a homogeneous group in themselves. As a consequence,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::86f176e10863519b8a5280c558e91282
https://doi.org/10.1136/ejhpharm-2020-eahpconf.97
https://doi.org/10.1136/ejhpharm-2020-eahpconf.97
Autor:
Mercedes Delgado-Valverde, C Cañete, M García-Palomo, M C Dávila-Pousa, Vicente Merino-Bohórquez, M Villaronga, R López-Rojas, M Cameán-Fernández, B Rodriguez-Marrodán
Publikováno v:
Digital.CSIC. Repositorio Institucional del CSIC
instname
instname
The Pharmaceutical Technology Working Group and Pediatric Pharmacy Working Group of the Spanish Society of Hospital Pharmacy (SEFH).
Pediatric patients present changing physiological features. Because of the lack of land suitable for commercial
Pediatric patients present changing physiological features. Because of the lack of land suitable for commercial
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::078f95cc4e21d4d966ea1fdd53d5c9f4
https://doi.org/10.1080/10837450.2018.1514520
https://doi.org/10.1080/10837450.2018.1514520
Autor:
MA Romo Murillo, R Farré Riba, M Sánchez Celma, JL Vinent Genestar, JM Català Foguet, M Villaronga Flaqué, D Gavrus Ion, JA Cuartero Lozano, A Diaz Cambron, F Bossacoma Busquets
Publikováno v:
Section 5: Patient Safety and Quality Assurance.
Background Oral liquid medicines, such as solutions and suspensions, are commonly given to young children, because they are easy to swallow and allow weight-based dosage. The development of oral medicines for paediatric patients often requires age-ap
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b368b93e59f06b5809e3bd80142ea80a
https://doi.org/10.1136/ejhpharm-2019-eahpconf.527
https://doi.org/10.1136/ejhpharm-2019-eahpconf.527
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.